The 14 most recent market catalysts affecting $APTV, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 25, 2026
Corporate Catalyst
Neutral
Impact 75
Transcript: Aptiv Q2 2026 Earnings Conference Call
Aptiv's Q2 2026 earnings call transcript reveals a mixed bag for investors. While the company achieved 2% revenue growth and expanded EBITDA margins, the significant takeaway is th…
Sep 15, 2026
Corporate Catalyst
Bearish
Impact 65
JP Morgan Downgrades Aptiv to Neutral, Lowers Price Target to $56
JP Morgan analyst Rajat Gupta downgraded Aptiv (APTV) from Overweight to Neutral and lowered the price target from $65 to $56. This action reflects a more conservative view on Apti…
Sep 9, 2026
Corporate Catalyst
Neutral
Impact 55
StoneX Initiates Coverage On Aptiv with Buy Rating, Announces Price Target of $75
StoneX analyst Mickey Legg has initiated coverage on Aptiv (APTV) with a 'Buy' rating and a $75 price target. This event is significant as new analyst coverage, especially with a p…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 55
Evercore ISI Group Maintains Outperform on Aptiv, Lowers Price Target to $70
Evercore ISI Group's decision to lower Aptiv's price target from $80 to $70, while maintaining an 'Outperform' rating, indicates a recalibration of expectations for the company. Th…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 55
Barclays Maintains Overweight on Aptiv, Lowers Price Target to $65
Barclays analyst Dan Levy maintained an 'Overweight' rating on Aptiv, signaling continued confidence in the company's fundamentals and long-term growth potential. However, the pric…
Aug 5, 2026
Corporate Catalyst
Bearish
Impact 65
RBC Capital Maintains Outperform on Aptiv, Lowers Price Target to $78
RBC Capital's decision to lower Aptiv's price target from $90 to $78, while maintaining an 'Outperform' rating, suggests that while the analyst still sees long-term value in the co…
Aug 5, 2026
Corporate Catalyst
Bearish
Impact 65
Morgan Stanley Downgrades Aptiv to Equal-Weight, Lowers Price Target to $55
Morgan Stanley analyst Andrew Percoco downgraded Aptiv (APTV) from 'Overweight' to 'Equal-Weight' and significantly lowered the price target from $71 to $55. This action signals a …
Aug 4, 2026
Corporate Catalyst
Bearish
Impact 85
Aptiv shares are trading lower after the company reported mixed Q2 financial results and issued Q3 guidance below estimates. Also, the company cut its FY26 guidance below estimates.
Aptiv's poor Q2 performance, coupled with a disappointing Q3 outlook and a significant cut to its long-term FY26 guidance, signals potential headwinds for the broader automotive te…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 75
Aptiv Raises FY2026 GAAP EPS Guidance from $3.85-$4.25 to $4.06-$4.26 vs $4.59 Est
Aptiv (APTV) has updated its financial outlook for fiscal year 2026, raising its GAAP EPS guidance from $3.85-$4.25 to $4.06-$4.26. This upward revision indicates improved internal…
Aug 4, 2026
Corporate Catalyst
Bearish
Impact 85
Aptiv Lowers FY2026 Adj EPS Guidance from $5.70-$6.10 to $5.60-$5.80 vs $6.19 Est; Lowers FY2026 Sales Guidance from $12.800B-$13.200B to $12.600B-$12.800B vs $15.104B Est
Aptiv's 8-K filing reveals a substantial downward revision to its FY2026 adjusted EPS and sales guidance. The new EPS range of $5.60-$5.80 is below the prior $5.70-$6.10 and signif…
Aug 4, 2026
Corporate Catalyst
Neutral
Impact 92
Aptiv Sees Q3 GAAP EPS $0.86-$0.96 vs $1.20 Est
Aptiv (APTV) has issued Q3 GAAP EPS guidance of $0.86-$0.96, falling short of the $1.20 analyst estimate. This pre-announcement indicates that the company expects to underperform m…
Aug 4, 2026
Corporate Catalyst
Neutral
Impact 92
Aptiv Sees Q3 Adj EPS $1.25-$1.35 vs $1.60 Est; Sees Sales $3.120B-$3.220B vs $3.295B Est
Aptiv's Q3 adjusted EPS guidance of $1.25-$1.35 is substantially lower than the analyst estimate of $1.60, representing a potential miss of 16-22%. Similarly, the sales guidance of…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 92
Aptiv Q2 Adj. EPS $1.63 Beats $1.43 Estimate, Sales $3.274B Miss $3.316B Estimate
Aptiv's Q2 earnings report presents a mixed picture for investors. The significant beat on adjusted EPS, exceeding estimates by nearly 14% and showing a 24.43% year-over-year incre…
Jul 13, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Aptiv, Raises Price Target to $90
RBC Capital analyst Tom Narayan maintained an 'Outperform' rating on Aptiv and raised the price target from $81 to $90. This action signals increased confidence from a prominent an…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.